New initiative launched to advance mRNA vaccine development against human avian influenza (H5N1)
29 July 2024, Geneva, Switzerland — A new project aiming to accelerate the development and accessibility of human avian influenza (H5N1) messenger RNA (mRNA) ...
Read moreDetails
